Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Micrus gets $21.2mm with Series D private placement

Executive Summary

Micrus (minimially-invasive devices to treat neurovascular disease) has raised $21.2mm with the private placement of Series D convertible preferred stock to lead investor NMT New Medical Technologies. MicroValue, PolyTechnos Venture-Partners, Dresdner Kleinwort Benson, UBS affiliate Aventic, and US investors and current shareholders also participated.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies